Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

HTS Assay Validation.

Iversen PW, Beck B, Chen YF, Dere W, Devanarayan V, Eastwood BJ, Farmen MW, Iturria SJ, Montrose C, Moore RA, Weidner JR, Sittampalam GS.

In: Sittampalam GS, Coussens NP, Brimacombe K, Grossman A, Arkin M, Auld D, Austin C, Baell J, Bejcek B, Chung TDY, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Hass JV, Inglese J, Iversen PW, Kahl SD, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Trask OJ Jr., Weidner JR, Xia M, Xu X, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.
2012 May 1 [updated 2012 Oct 1].

2.

Assay Guidance Manual [Internet].

Sittampalam GS, Coussens NP, Brimacombe K, Grossman A, Arkin M, Auld D, Austin C, Baell J, Bejcek B, Chung TDY, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Hass JV, Inglese J, Iversen PW, Kahl SD, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Trask OJ Jr., Weidner JR, Xia M, Xu X, editors.

Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.

3.

Novel trends in high-throughput screening.

Mayr LM, Bojanic D.

Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21. Review.

PMID:
19775937
4.

Open access high throughput drug discovery in the public domain: a Mount Everest in the making.

Roy A, McDonald PR, Sittampalam S, Chaguturu R.

Curr Pharm Biotechnol. 2010 Nov;11(7):764-78. Review.

5.

Receptor Binding Assays for HTS and Drug Discovery.

Auld DS, Farmen MW, Kahl SD, Kriauciunas A, McKnight KL, Montrose C, Weidner JR.

In: Sittampalam GS, Coussens NP, Brimacombe K, Grossman A, Arkin M, Auld D, Austin C, Baell J, Bejcek B, Chung TDY, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Hass JV, Inglese J, Iversen PW, Kahl SD, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Trask OJ Jr., Weidner JR, Xia M, Xu X, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.
2012 May 1 [updated 2012 Oct 1].

6.

Validation of high throughput sequencing and microbial forensics applications.

Budowle B, Connell ND, Bielecka-Oder A, Colwell RR, Corbett CR, Fletcher J, Forsman M, Kadavy DR, Markotic A, Morse SA, Murch RS, Sajantila A, Schmedes SE, Ternus KL, Turner SD, Minot S.

Investig Genet. 2014 Jul 30;5:9. doi: 10.1186/2041-2223-5-9. eCollection 2014. Review.

7.

Adapting high-throughput screening methods and assays for biocontainment laboratories.

Rasmussen L, Tigabu B, White EL, Bostwick R, Tower N, Bukreyev A, Rockx B, LeDuc JW, Noah JW.

Assay Drug Dev Technol. 2015 Jan-Feb;13(1):44-54. doi: 10.1089/adt.2014.617. Review.

8.
9.

Which aspects of HTS are empirically correlated with downstream success?

Bender A, Bojanic D, Davies JW, Crisman TJ, Mikhailov D, Scheiber J, Jenkins JL, Deng Z, Hill WA, Popov M, Jacoby E, Glick M.

Curr Opin Drug Discov Devel. 2008 May;11(3):327-37. Review.

PMID:
18428086
10.

Origin and evolution of high throughput screening.

Pereira DA, Williams JA.

Br J Pharmacol. 2007 Sep;152(1):53-61. Epub 2007 Jul 2. Review.

11.

Technological advances in high-throughput screening.

Liu B, Li S, Hu J.

Am J Pharmacogenomics. 2004;4(4):263-76. Review.

PMID:
15287820
12.

Integrating biophysics with HTS-driven drug discovery projects.

Folmer RH.

Drug Discov Today. 2016 Mar;21(3):491-8. doi: 10.1016/j.drudis.2016.01.011. Epub 2016 Jan 28. Review.

PMID:
26826422
13.

Functional cell-based assays in microliter volumes for ultra-high throughput screening.

Wunder F, Kalthof B, Müller T, Hüser J.

Comb Chem High Throughput Screen. 2008 Aug;11(7):495-504. Review.

PMID:
18694386
14.

Inhibition of Protein-Protein Interactions: Non-Cellular Assay Formats.

Arkin MR, Glicksman MA, Fu H, Havel JJ, Du Y.

In: Sittampalam GS, Coussens NP, Brimacombe K, Grossman A, Arkin M, Auld D, Austin C, Baell J, Bejcek B, Chung TDY, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Hass JV, Inglese J, Iversen PW, Kahl SD, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Trask OJ Jr., Weidner JR, Xia M, Xu X, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.
2012 Mar 18 [updated 2012 Oct 1].

15.

[Assay in high throughput screening].

Arai K.

Nihon Yakurigaku Zasshi. 2001 Aug;118(2):81-8. Review. Japanese.

PMID:
11530683
16.

Design and implementation of high throughput screening assays.

Macarrón R, Hertzberg RP.

Mol Biotechnol. 2011 Mar;47(3):270-85. doi: 10.1007/s12033-010-9335-9. Review.

PMID:
20865348
17.

Design considerations for high-throughput screening and in vitro diagnostic assays.

Achyuthan KE, Whitten DG.

Comb Chem High Throughput Screen. 2007 Jul;10(6):399-412. Review.

PMID:
17896936
18.

An overview of drug screening using primary and embryonic stem cells.

Eglen RM, Gilchrist A, Reisine T.

Comb Chem High Throughput Screen. 2008 Aug;11(7):566-72. Review.

PMID:
18694393
19.

An infrastructure for high-throughput microscopy: instrumentation, informatics, and integration.

Vaisberg EA, Lenzi D, Hansen RL, Keon BH, Finer JT.

Methods Enzymol. 2006;414:484-512. Review.

PMID:
17110208
20.

High-throughput screening assays for the identification of chemical probes.

Inglese J, Johnson RL, Simeonov A, Xia M, Zheng W, Austin CP, Auld DS.

Nat Chem Biol. 2007 Aug;3(8):466-79. Review.

PMID:
17637779

Supplemental Content

Support Center